Privacy & Legal
FAQsFAQsFAQs
Concept Medical is as innovation -driven, intellectual property focused organization developing advanced medical devices to address critical unmet clinical needs in Cardiovascular and peripheral vascular interventions. Guided by the mission “Converting Concepts into Reality”, We specialize in pioneering sirolimus-based drug delivery platforms designed to enhance patient’s outcome globally, setting new standards in vascular therapy
Concept Medical is headquartered in Tampa, Florida, and operates globally in over 80 countries, with strong footprints in research, manufacturing, and marketing.
At Concept Medical, we distinguish ourselves through.
- Exclusive focus on sirolimus-based technologies
- We support our innovations withe robust portfolio of international clinical trials, Validating safety and efficacy across diverse patient population
- Innovation Driven By patients’ safety and Physician’s Needs.
We provide solutions for:
- Coronary Artery Disease (CAD)
- Peripheral Artery Disease (PAD)
- Arteriovenous Fistula/Graft (AVF/AVG) maintenance
- Vasculogenic Erectile Dysfunction
A Drug Coated Balloon (DCB) is a balloon coated with drug/medicine used in angioplasty that opens blocked vessels and delivers medication to maintain patency without stenting.
Sirolimus:
- Controls cell growth
- Minimizes inflammation
- Supports safe and effective healing
It is widely regarded as more biocompatible than alternatives like paclitaxel.
A Sirolimus Coated Balloon is a balloon catheter that opens narrowed vessels and delivers sirolimus, a proven antiproliferative drug, without leaving a stent behind.
It restores blood flow by:
- Mechanically widening the artery
- Delivering sirolimus to prevent re-narrowing
- Allowing natural healing without permanent implants
Sirolimus offers:
- Superior safety and anti-restenotic effects
- Reduced inflammation
- Longer drug retention
It’s ideal for both coronary and peripheral applications.
MagicTouch, developed by Concept Medical, was the world’s first commercially approved SCB for coronary use (CE Mark in 2016). It offers a safer alternative to paclitaxel-coated balloons with no implant left behind.
MagicTouch is our proprietary Sirolimus-Coated Balloon (SCB) platform. It delivers sirolimus directly to vessel walls during angioplasty without leaving any permanent implant.
- MagicTouch SCB – For coronary artery disease
- MagicTouch PTA – For peripheral arterial disease
- MagicTouch AVF – For dialysis-related fistulas and grafts
- MagicTouch ED – For vasculogenic erectile dysfunction
MagicTouch uses Nanolute technology, enabling:
- Precise sirolimus delivery
- Uniform coating
- No implant left behind
- Polymer free
This distinguishes it from older paclitaxel-based balloons.
Nanolute is a proprietary Sub-micron?
platform that:
- Enhances drug delivery
- Increases tissue retention
- Reduces systemic exposure
It enables efficient and safer vascular therapy.
No. Drug Coated Balloons by Concept Medical are non-implant technologies only the drug is delivered; the device is then removed.
We have received five IDE approvals for clinical trials of the MagicTouch SCB platform in the U.S.:
- Coronary In-Stent Restenosis (ISR)
- Below-The-Knee (BTK) PAD
- Coronary Small Vessel Disease
- Superficial Femoral Artery (SFA) Disease
- Arteriovenous Fistula (AVF) for Hemodialysis Access
Please visit the Products section on our official website to explore indications, specifications, and clinical applications.
Follow us on social media or subscribe to our newsletter for updates on clinical trials, product launches, and global activities.
Email us at info@conceptmedical.com or reach us via the Contact Us page on our website.
Visit our Clinical Trial section on the Concept Medical website for study results, outcomes, and publications.
A DES is a metallic stent coated with a drug like sirolimus that is gradually released to prevent artery re-narrowing (restenosis) after angioplasty.
- Abluminus DES+ – Abluminal sirolimus coating, Fusion coating + biodegradable polymer
- Abluminus NP – Polymer-free sirolimus stent
It features:
- Abluminal-only coating
- Biodegradable polymer
- Targeted healing for diabetic and high-risk patients
- Fusion Coating – Coating on the stent and exposed parts of the balloon facilitates homogenous drug delivery, which addresses diffused proliferative disease and focal restenosis.
Abluminus NP is polymer-free, minimizing long-term inflammation and foreign body response while supporting faster healing.
Envisolution is our surface modification and drug delivery platform, used in Abluminus stents.
Key features:
- Abluminal-only sirolimus coating
- Uniform drug delivery
- Faster endothelialization
- Reduced inflammation
- Fusion Coating – Coating on the stent and exposed parts of the balloon facilitates homogenous drug delivery, which addresses diffused proliferative disease and focal restenosis.
Concept Medical is as innovation -driven, intellectual property focused organization developing advanced medical devices to address critical unmet clinical needs in Cardiovascular and peripheral vascular interventions. Guided by the mission “Converting Concepts into Reality”, We specialize in pioneering sirolimus-based drug delivery platforms designed to enhance patient’s outcome globally, setting new standards in vascular therapy
Concept Medical is headquartered in Tampa, Florida, and operates globally in over 80 countries, with strong footprints in research, manufacturing, and marketing.
At Concept Medical, we distinguish ourselves through.
- Exclusive focus on sirolimus-based technologies
- We support our innovations withe robust portfolio of international clinical trials, Validating safety and efficacy across diverse patient population
- Innovation Driven By patients’ safety and Physician’s Needs.
We provide solutions for:
- Coronary Artery Disease (CAD)
- Peripheral Artery Disease (PAD)
- Arteriovenous Fistula/Graft (AVF/AVG) maintenance
- Vasculogenic Erectile Dysfunction
A Drug Coated Balloon (DCB) is a balloon coated with drug/medicine used in angioplasty that opens blocked vessels and delivers medication to maintain patency without stenting.
A DCB is inflated at the blockage site to restore blood flow while delivering a drug to the artery wall, preventing re-narrowing. It’s then removed, leaving no implant behind.
A Sirolimus Coated Balloon is a balloon catheter that opens narrowed vessels and delivers sirolimus, a proven antiproliferative drug, without leaving a stent behind.
It restores blood flow by:
- Mechanically widening the artery
- Delivering sirolimus to prevent re-narrowing
- Allowing natural healing without permanent implants
MagicTouch is our proprietary Sirolimus-Coated Balloon (SCB) platform. It delivers sirolimus directly to vessel walls during angioplasty without leaving any permanent implant.
- MagicTouch SCB – For coronary artery disease
- MagicTouch PTA – For peripheral arterial disease
- MagicTouch AVF – For dialysis-related fistulas and grafts
- MagicTouch ED – For vasculogenic erectile dysfunction
Sirolimus:
- Controls cell growth
- Minimizes inflammation
- Supports safe and effective healing
It is widely regarded as more biocompatible than alternatives like paclitaxel.
No. Drug Coated Balloons by Concept Medical are non-implant technologies only the drug is delivered; the device is then removed.
Please visit the Products section on our official website to explore indications, specifications, and clinical applications.
MagicTouch, developed by Concept Medical, was the world’s first commercially approved SCB for coronary use (CE Mark in 2016). It offers a safer alternative to paclitaxel-coated balloons with no implant left behind.
We have received five IDE approvals for clinical trials of the MagicTouch SCB platform in the U.S.:
- Coronary In-Stent Restenosis (ISR)
- Below-The-Knee (BTK) PAD
- Coronary Small Vessel Disease
- Superficial Femoral Artery (SFA) Disease
- Arteriovenous Fistula (AVF) for Hemodialysis Access
MagicTouch uses Nanolute technology, enabling:
- Precise sirolimus delivery
- Uniform coating
- No implant left behind
- Polymer free
This distinguishes it from older paclitaxel-based balloons.
Sirolimus offers:
- Superior safety and anti-restenotic effects
- Reduced inflammation
- Longer drug retention
It’s ideal for both coronary and peripheral applications.
Nanolute is a proprietary Sub-micron?
platform that:
- Enhances drug delivery
- Increases tissue retention
- Reduces systemic exposure
It enables efficient and safer vascular therapy.
We are leading one of the world’s largest SCB clinical trial programs across North America, Europe, Asia, and Latin America, strengthening global evidence for sirolimus-coated technologies.
Visit our Clinical Trial section on the Concept Medical website for study results, outcomes, and publications.
A DES is a metallic stent coated with a drug like sirolimus that is gradually released to prevent artery re-narrowing (restenosis) after angioplasty.
- Abluminus DES+ – Abluminal sirolimus coating, Fusion coating + biodegradable polymer
- Abluminus NP – Polymer-free sirolimus stent
It features:
- Abluminal-only coating
- Biodegradable polymer
- Targeted healing for diabetic and high-risk patients
- Fusion Coating – Coating on the stent and exposed parts of the balloon facilitates homogenous drug delivery, which addresses diffused proliferative disease and focal restenosis.
Abluminus NP is polymer-free, minimizing long-term inflammation and foreign body response while supporting faster healing.
Envisolution is our surface modification and drug delivery platform, used in Abluminus stents.
Key features:
- Abluminal-only sirolimus coating
- Uniform drug delivery
- Faster endothelialization
- Reduced inflammation
- Fusion Coating – Coating on the stent and exposed parts of the balloon facilitates homogenous drug delivery, which addresses diffused proliferative disease and focal restenosis.
Follow us on social media or subscribe to our newsletter for updates on clinical trials, product launches, and global activities.
Email us at info@conceptmedical.com or reach us via the Contact Us page on our website.